Pharmacokinetics and metabolism of the novel anticonvulsant agent N- (2,6-dimethylphenyl)-5-methyl-3-isoxazolecarboxamide (D2624) in rats and humans

Drug Metabolism and Disposition

Volumn 25, Issue 1, 1997, Pages 40-46

  Martin, Steven W ^b   Bishop, Frances E ^b   Kerr, Brad M ^b   Moor, Markus ^b   Moore, Martha ^b   Sheffels, Pamela ^b   Rashed, Mohammed ^b   Slatter, J Greg ^b   Berthon Cédille, Laurence ^b   Lepage, Francis ^b   Descombe, Jean Jacques ^b   Picard, Michel ^b   Baillie, Thomas A ^b   Levy, René H ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; D 2624; D 3017; D 3270; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ANTICONVULSANT ACTIVITY; AREA UNDER THE CURVE; ARTICLE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DEGRADATION; DRUG EFFECT; DRUG OXIDATION; HUMAN; HUMAN EXPERIMENT; LIVER MICROSOME METABOLISM; MALE; NONHUMAN; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; SPECIES DIFFERENCE;

ANILINE COMPOUNDS; ANIMALS; ANTICONVULSANTS; BIOLOGICAL AVAILABILITY; HUMANS; ISOXAZOLES; MALE; MICROSOMES, LIVER; NAD; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0031012605     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. B. G. Covino and H. G. Vassallo: In "Local Anesthetics; Mechanism of Action and Clinical Use" (B. G. Covino and H. G. Vassallo, eds.), pp. 129-130. Grune & Stratton, New York, 1976.
2. R. L. Krall, J. K. Penry, B. G. White, H. J. Kupferberg, and E. A. Swinyard: Antiepileptic drug development. II. Anticonvulsant drug screening. Epilepsia 19, 409-428 (1978).
3. F. Lepage, F. Tombret, G. Cuvier, A. Marivain, and J. M. Gillardin: New N-aryl isoxazolecarboxamides and N-isoxazolylbenzamides as anticonvulsant agents. Eur. J. Med. Chem. 27, 581-593 (1992).
4. J. M. Gillardin, M. Verleye, P. Girard, and F. Lepage: Comparison of anticonvulsant profile of lidocaine and a new structurally related N-aryl isoxazolecarboxamide (D2624). Epilepsia 34 (Suppl. 2), 94 (1993).
5. J. B. Keenaghan and R. N. Boyes: The tissue distribution, metabolism and excretion of lidocaine in rats, guinea pigs, dogs and man. J. Pharmacol. Exp. Ther. 180, 454-463 (1972).
6. G. Magnusson, N.-O. Bodin, and E. Hansson: Hepatic changes in dogs and rats induced by xylidine isomers. Acta Pathol. Microbiol. Scand. 79, 639-648 (1971).
7. 14C]-2,6-dimethyl aniline to DNA of rat liver and ethmoid turbinate. J. Toxicol. Environ. Health 27, 85-94 (1989).
8. E. J. Corey and G. Schmidt: Useful procedures for the oxidation of alcohols involving pyridinium dichromate in a protic media. Tetrahedron Lett. 5, 399-402 (1979).
9. E. Dalcanale and F. Montanari: Selective oxidation of aldehydes to carboxylic acids with sodium chlorite-hydrogen peroxide. J. Org. Chem. 51, 567-569 (1986).
10. S. J. Tremont and H. U. Rahman: Ortho alkylation of acetanilides using alkyl halides and palladium acetate. J. Am. Chem. Soc. 106, 5759-5760 (1984).
11. R. T. Coutts, G. A. Torok-Both, Y. K. Tam, L. V. Chu, and F. M. Pasutto: Acetylation in aqueous solution and identification of derivatives by combined gas chromatography/mass spectrometry. Biomed. Environ. Mass. Spectrom. 14, 173-182 (1987).
12. K. E. Thummel, E. D. Kharasch, T. Podoll, and K. Kunze: Human liver microsomal enflurane defluorination catalyzed by P-450 2E1. Drug Metab. Dispos. 21, 350-357 (1993).